Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain

Recent studies have shown that multiple sclerosis (ms) and schizophrenia share similarities in some respects, including white matter damage and neuroinflammation. on the other hand, adenosine was reported to promote oligodendrocyte precursor maturation and remyelinating while influencing microglia activation. the aim of the present study was to examine possible beneficial effects of adenosine on the recovery of cuprizone (cpz)-exposed mouse which has been used as an animal model of ms and schizophrenia as the cpz-exposed mouse presents demyelination, oligodendrocyte loss, microglia accumulation, as well as behavioral changes. as reported previously, c57bl/6 mice, after fed cpz for 5 weeks, showed salient demyelination and oligodendrocyte loss in the cerebral cortex (ctx) and hippocampus, in addition to displaying anxiety-like behavior, spatial working memory deficit, and social interaction impairment. administration of adenosine for 7 days during the recovery period after cpz withdrawal promoted the behavioral recovery of cpz-exposed mice and accelerated the remyelinating process in the brains of mice after cpz withdrawal in a dose-dependent manner. in addition, the effective dose (10 mg/kg) of adenosine inhibited microglia activation and suppressed abnormal elevation of the pro-inflammatory cytokines il-1β and tnf-α in ctx and hippocampus, but increased levels of the anti-inflammatory cytokines il-4 or il-10 in the same brain regions during the remyelinating process. these results provided an evidence-based rationale for the application of adenosine or its analogues as add-on therapy for schizophrenia.